Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Cytarabine
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 500 mg
- Dosage form
- Injection
- Pack
- 1's
- Registration no.
- 022545
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 1,301.56, effective 1 Jul 2024.
Cite this price history
MedInfoBase. Cytosar 500 mg, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/cytosar-500-mg-022545-1s-pfizer-pakistan-limited/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,301.56 | 2024-07-01 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 022545Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
